Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence.

Clicks: 411
ID: 63640
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #7 of 18 articles by views in the journal of allergy and clinical immunology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
The selection of pharmacotherapy for patients with allergic rhinitis aims to control the disease and depends on many factors. Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidelines have considerably improved the treatment of allergic rhinitis. However, there is an increasing trend toward use of real-world evidence to inform clinical practice, especially because randomized controlled trials are often limited with regard to the applicability of results. The Contre les Maladies Chroniques pour un Vieillissement Actif (MACVIA) algorithm has proposed an allergic rhinitis treatment by a consensus group. This simple algorithm can be used to step up or step down allergic rhinitis treatment. Next-generation guidelines for the pharmacologic treatment of allergic rhinitis were developed by using existing GRADE-based guidelines for the disease, real-world evidence provided by mobile technology, and additive studies (allergen chamber studies) to refine the MACVIA algorithm.
Reference Key
bousquet2019nextgenerationthe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Bousquet, Jean;Schünemann, Holger J;Togias, Akdis;Bachert, Claus;Erhola, Martina;Hellings, Peter W;Klimek, Ludger;Pfaar, Oliver;Wallace, Dana;Ansotegui, Ignacio;Agache, Ioana;Bedbrook, Anna;Bergmann, Karl-Christian;Bewick, Mike;Bonniaud, Philippe;Bosnic-Anticevich, Sinthia;Bossé, Isabelle;Bouchard, Jacques;Boulet, Louis-Philippe;Brozek, Jan;Brusselle, Guy;Calderon, Moises A;Canonica, Walter G;Caraballo, Luis;Cardona, Vicky;Casale, Thomas;Cecchi, Lorenzo;Chu, Derek K;Costa, Elisio M;Cruz, Alvaro A;Czarlewski, Wienczyslawa;D'Amato, Gennaro;Devillier, Philippe;Dykewicz, Mark;Ebisawa, Motohiro;Fauquert, Jean-Louis;Fokkens, Wytske J;Fonseca, Joao A;Fontaine, Jean-François;Gemicioglu, Bilun;van Wijk, Roy Gerth;Haahtela, Tari;Halken, Susanne;Ierodiakonou, Despo;Iinuma, Tomohisa;Ivancevich, Juan-Carlos;Jutel, Marek;Kaidashev, Igor;Khaitov, Musa;Kalayci, Omer;Kleine Tebbe, Jorg;Kowalski, Marek L;Kuna, Piotr;Kvedariene, Violeta;La Grutta, Stefania;Larenas-Linemann, Désirée;Lau, Susanne;Laune, Daniel;Le, Lan;Lieberman, Philipp;Lodrup Carlsen, Karin C;Lourenço, Olga;Marien, Gert;Carreiro-Martins, Pedro;Melén, Erik;Menditto, Enrica;Neffen, Hugo;Mercier, Gregoire;Mosgues, Ralph;Mullol, Joaquim;Muraro, Antonella;Namazova, Leyla;Novellino, Ettore;O'Hehir, Robyn;Okamoto, Yoshitaka;Ohta, Ken;Park, Hae Sim;Panzner, Petr;Passalacqua, Giovanni;Pham-Thi, Nhan;Price, David;Roberts, Graham;Roche, Nicolas;Rolland, Christine;Rosario, Nelson;Ryan, Dermot;Samolinski, Boleslaw;Sanchez-Borges, Mario;Scadding, Glenis K;Shamji, Mohamed H;Sheikh, Aziz;Bom, Ana-Maria Todo;Toppila-Salmi, Sanna;Tsiligianni, Ioana;Valentin-Rostan, Marylin;Valiulis, Arunas;Valovirta, Erkka;Ventura, Maria-Teresa;Walker, Samantha;Waserman, Susan;Yorgancioglu, Arzu;Zuberbier, Torsten;, ;
Journal the journal of allergy and clinical immunology
Year 2019
DOI
S0091-6749(19)31187-X
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.